FDA Approved: TIVICAY — Original Application (ViiV Healthcare Company)

View source ↗

Summary

The FDA approved the original NDA for TIVICAY (dolutegravir), authorizing its use for treating HIV-1 infection. The submission was from ViiV Healthcare Company.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Tivicay (dolutegravir)

Snippet

ORIG AP for TIVICAY (DOLUTEGRAVIR SODIUM)